Articles in section Mergers & Acquisitions

<< Licensing

627 articles

Opinion & Analysis >>

Pages 1 2 3 4 5 .. 63

Next >>

Amgen to Acquire Horizon Therapeutics for US$28.3 B Published: 19 Dec-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 12
AstraZeneca Bolsters Pipeline with Neogene Therapeutics and C4X Discovery Deals Published: 9 Dec-2022
By: Lucy Haggerty & Amit Kaushik
Abstract Fulltext:
Volume: 2022 Issue: 12
Merck & Co. Acquires Imago BioSciences for US$1.35 B Published: 26 Nov-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 11
J&J to Acquire Abiomed for US$16.6 B Published: 11 Nov-2022
By: Ayush Saxena
Abstract Fulltext:
Volume: 2022 Issue: 11
Incyte to Acquire Villaris Therapeutics for US$1.43 B Published: 26 Oct-2022
By: Amit Kaushik
Abstract Fulltext:
Volume: 2022 Issue: 10
AstraZeneca to Acquire LogicBio for US$68.2 M Published: 20 Oct-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 10
Genfit Buys Versantis to Rebuild its Liver Disease Portfolio Published: 21 Sep-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 9
Novo Nordisk to Acquire Forma Therapeutics for US$1.1 B Published: 13 Sep-2022
By: Ashish Tripathi
Abstract Fulltext:
Volume: 2022 Issue: 9
Roche Acquires Good Therapeutics for US$250 M Upfront Published: 10 Sep-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 9
Alcon to Acquire Aerie Pharmaceuticals for US$770 M Published: 26 Aug-2022
By: Lucy Haggerty
Abstract Fulltext:
Volume: 2022 Issue: 8

Login

Username:

Password:

Keep me logged in